Review article · 2013

Therapeutics of Alzheimer's disease: Past, present and future

Ruban Anand, Kiran Dip Gill, Abbas Ali Mahdi

Neuropharmacology, 76, 27–50 · Published 25 July 2013 · DOI 10.1016/j.neuropharm.2013.07.004

View at the publisherCite this paper

In brief

“Therapeutics of Alzheimer's disease: Past, present and future” is a 2013 review article by Ruban Anand and 2 co-authors, published in Neuropharmacology. OpenAlex counts 769 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
769
Most cited in
2019 (92)
Field-weighted impact
4.50
References
415
Authors
3

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Anand, R., Gill, K. D., & Mahdi, A. A. (2013). Therapeutics of Alzheimer's disease: Past, present and future. Neuropharmacology, 76, 27–50. https://doi.org/10.1016/j.neuropharm.2013.07.004

MLA 9

Anand, Ruban, et al. “Therapeutics of Alzheimer's disease: Past, present and future.” Neuropharmacology, vol. 76, 2013, pp. 27–50. https://doi.org/10.1016/j.neuropharm.2013.07.004.

Chicago

Anand, Ruban, Kiran Dip Gill, and Abbas Ali Mahdi. 2013. “Therapeutics of Alzheimer's disease: Past, present and future.” Neuropharmacology 76: 27–50. https://doi.org/10.1016/j.neuropharm.2013.07.004.

Harvard

Anand, R., Gill, K. D. and Mahdi, A. A. (2013) ‘Therapeutics of Alzheimer's disease: Past, present and future’, Neuropharmacology, 76, pp. 27–50. doi:10.1016/j.neuropharm.2013.07.004.

IEEE

R. Anand, K. D. Gill, and A. A. Mahdi, “Therapeutics of Alzheimer's disease: Past, present and future,” Neuropharmacology, vol. 76, pp. 27–50, 2013, doi: 10.1016/j.neuropharm.2013.07.004.

BibTeX

@article{anand2013therapeutics,
  title     = {{Therapeutics of Alzheimer's disease: Past, present and future}},
  author    = {Anand, Ruban and Gill, Kiran Dip and Mahdi, Abbas Ali},
  journal   = {Neuropharmacology},
  year      = {2013},
  volume    = {76},
  pages     = {27--50},
  doi       = {10.1016/j.neuropharm.2013.07.004},
  url       = {https://doi.org/10.1016/j.neuropharm.2013.07.004}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20177979
20189191
20199292
20208888
20216565
20225151
20236262
20245151
20253333
20261616

Its field-weighted citation impact is 4.50: it has been cited 4.50 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • Alzheimer's disease therapeutics
  • acetylcholinesterase inhibitors
  • memantine
  • disease-modifying therapy
  • therapeutic target
  • dementia

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Anand, R., Gill, K. D., & Mahdi, A. A. (2013). Therapeutics of Alzheimer's disease: Past, present and future. Neuropharmacology, 76, 27–50. https://doi.org/10.1016/j.neuropharm.2013.07.004

How many times has this paper been cited?

769 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Ruban Anand, Kiran Dip Gill, Abbas Ali Mahdi.

What is the DOI of this paper?

10.1016/j.neuropharm.2013.07.004. The permanent link is https://doi.org/10.1016/j.neuropharm.2013.07.004.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.